News Sentiment

NGNE sentiment intelligence

Neurogene Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 39.63 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

+12.1% over one week, +36.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

(NGNE) Volatility Zones as Tactical Triggers

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 12.1% Price confirming higher
Trend fit Trend active 36.2% over four weeks
Fair value 56.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 37
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Traders Daily 13
Stock Titan 13
Market source 6
Business Wire 6
MT Newswires 4
TradingView 3
simplywall.st 3
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 10
Deals and strategy 6
Guidance 4
Analyst action 4
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
Stock Traders Daily Direct company coverage

(NGNE) Volatility Zones as Tactical Triggers

This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE) using AI models, highlighting strong sentiment across all horizons supporting an overweight bias. It outlines distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored

Tone
Positive 70/100
Event
Market update
Published
12 Jul 2026 19:41
Source
Stock Traders Daily
Stock Traders Daily Direct company coverage

Price-Driven Insight from (NGNE) for Rule-Based Strategy

This article provides a price-driven insight for Neoleukin Therapeutics Inc. (NASDAQ: NGNE) based on AI-generated signals for July 01, 2026. It highlights strong sentiment supporting an overweight bias, an ongoing breakout, and no resistance levels above the current price. The an

Tone
Positive 73/100
Event
Market update
Published
01 Jul 2026 19:09
Source
Stock Traders Daily
Stock Traders Daily Direct company coverage

(NGNE) Price Dynamics and Execution-Aware Positioning

This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE), highlighting strong sentiment across all horizons supporting an overweight bias. It outlines detailed institutional trading strategies, including long, momentum breakout, and short setups, with specific entry, targ

Tone
Positive 66/100
Event
Market update
Published
20 Jun 2026 17:34
Source
Stock Traders Daily
Stock Traders Daily Direct company coverage

(NGNE) Movement as an Input in Quant Signal Sets

This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE) using AI models, indicating a neutral near-term outlook with potential mid-term strong sentiment stalling. It highlights a significant short setup with a 79.2:1 risk-reward ratio, targeting a 23.2% downside. The rep

Tone
Negative 38/100
Event
Guidance
Published
18 May 2026 13:48
Source
Stock Traders Daily
Associated Press Direct company coverage

Neurogene: Q1 Earnings Snapshot

Tone
Neutral 50/100
Event
Earnings
Published
12 May 2026 20:25
Source
Associated Press